» Articles » PMID: 36465167

Exosomes As a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2022 Dec 5
PMID 36465167
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes, which contain miRNA, have been receiving growing attention in cardiovascular therapy because of their role in mediating cell-cell communication, autophagy, apoptosis, inflammation, and angiogenesis. Several studies have suggested that miRNA derived from exosomes can be used to detect myocardial infarctions (MI) in patients. Basic research also suggests that exosomes could serve as a potential therapeutic target for treating acute myocardial infarction. Ischemia/reperfusion (IR) injury is associated with adverse cardiac events after acute MI. We aim to review the potential benefits and mechanisms of exosomes in treating MI and IR injury.

Citing Articles

Cardioprotective effects of hUCMSCs-Exosi-EGR1 MN patch in MI/RI by modulating oxidative stress and mitophagy.

Huang C, Zhang X, Wu S, Chang Q, Zheng Z, Xu J Mater Today Bio. 2025; 31:101500.

PMID: 39944530 PMC: 11815289. DOI: 10.1016/j.mtbio.2025.101500.


Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect ischemia-reperfusion injury.

Li Y, Wang X, Meng X, Xia C, Yang C, Wang J Mol Med. 2024; 30(1):273.

PMID: 39719560 PMC: 11668014. DOI: 10.1186/s10020-024-01048-7.


Neutrophil N1 polarization induced by cardiomyocyte-derived extracellular vesicle miR-9-5p aggravates myocardial ischemia/reperfusion injury.

Zhang Y, Li X, Dai Y, Han Y, Wei X, Wei G J Nanobiotechnology. 2024; 22(1):632.

PMID: 39415256 PMC: 11484374. DOI: 10.1186/s12951-024-02902-w.


Mesenchymal stem cell-derived exosomal mir-21-5p inhibits YAP1 expression and improves outcomes in myocardial infarction.

Ji Z, Wang C BMC Cardiovasc Disord. 2024; 24(1):547.

PMID: 39385107 PMC: 11465913. DOI: 10.1186/s12872-024-04197-z.


Therapeutic application of adipose-derived stromal vascular fraction in myocardial infarction.

Gareev I, Beylerli O, Ilyasova T, Ahmad A, Shi H, Chekhonin V iScience. 2024; 27(5):109791.

PMID: 38736548 PMC: 11088339. DOI: 10.1016/j.isci.2024.109791.


References
1.
Carvalho E, Verma P, Hourigan K, Banerjee R . Myocardial infarction: stem cell transplantation for cardiac regeneration. Regen Med. 2015; 10(8):1025-43. DOI: 10.2217/rme.15.63. View

2.
Zhang C, Shao K, Liu C, Li C, Yu B . Hypoxic preconditioning BMSCs-exosomes inhibit cardiomyocyte apoptosis after acute myocardial infarction by upregulating microRNA-24. Eur Rev Med Pharmacol Sci. 2019; 23(15):6691-6699. DOI: 10.26355/eurrev_201908_18560. View

3.
Xiao C, Wang K, Xu Y, Hu H, Zhang N, Wang Y . Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b. Circ Res. 2018; 123(5):564-578. DOI: 10.1161/CIRCRESAHA.118.312758. View

4.
Golforoush P, Yellon D, Davidson S . Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol. 2020; 115(6):73. PMC: 7704510. DOI: 10.1007/s00395-020-00829-5. View

5.
Huang H, Xu Z, Qi Y, Zhang W, Zhang C, Jiang M . Exosomes from SIRT1-Overexpressing ADSCs Restore Cardiac Function by Improving Angiogenic Function of EPCs. Mol Ther Nucleic Acids. 2020; 21:737-750. PMC: 7412761. DOI: 10.1016/j.omtn.2020.07.007. View